FLORDIS has released details of
a clinical observational study of its
Femular Ze450 unique black cohosh
extract, which has for the first time
proven a dose dependent effect in
relieving menopausal symtoms.
The study, published recently
in the Phytomedicine journal,
also demonstrated efficacy and
tolerability for up to nine months.
Dr Lily Tomas, president of the
Australasian Integrative Medicine
Association said it is critical that
clinically relevant and statistically
significant trials are performed on
interventions such as black cohosh.
She said the Femular study
provides healthcare professionals
the “much needed confidence to
continue what has already been
observed in clinical practice: the
value of black cohosh in the relief
of menopausal symptoms.”The above article was sent to subscribers in Pharmacy Daily's issue from 16 Sep 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Sep 13
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.